MARY BOGUSH: Open Payments
NPI 1467824821 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 42 payments from 16 companies in 2025. Trend: 2023 $728 · 2024 $1,021 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $117 |
| Calliditas Therapeutics US Inc. | 4 | $84 |
| Lilly USA, LLC | 3 | $72 |
| Mallinckrodt Hospital Products Inc. | 2 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ANI Pharmaceuticals, Inc. | 2 | $64 |
| Ardelyx, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| Fresenius USA Marketing, Inc. | 2 | $48 |
Products named: Kerendia, JARDIANCE, TARPEYO, ACTHAR, JYNARQUE, PURIFIED CORTROPHIN GEL, TAVNEOS, IBSRELA.
Industry payments across DE — which companies pay providers there.
